Crithmum maritimum (Samphire)
Crithmum maritimum, commonly called rock samphire, is a coastal halophyte rich in phenolic compounds including chlorogenic acid, caffeic acid, and flavonoids that drive its antioxidant and hepatoprotective activity. These phytochemicals scavenge free radicals and modulate oxidative stress pathways, with preliminary animal data suggesting restoration of liver enzyme levels.

Origin & History
Crithmum maritimum, commonly known as rock samphire or sea fennel, is a succulent perennial plant from the Apiaceae family that grows on rocky shores and beaches in Mediterranean, Tunisian, and Croatian coastal regions. The whole plant is used to produce essential oils via steam distillation or solvent extraction, alongside aqueous extracts from leaves and shoots.
Historical & Cultural Context
Historically used as a functional food in coastal cuisines for its nutrient density, containing sugars, organic acids, and minerals. The plant is recognized by the USDA as a nutrient-dense food and valued for its aromatic and succulent properties in ethnobotanical traditions.
Health Benefits
• Hepatoprotective effects demonstrated in animal studies, with extracts restoring liver markers and reducing oxidative stress (preliminary evidence) • Antioxidant activity shown through in vitro radical scavenging assays (ABTS, DPPH, FRAP methods) (preliminary evidence) • Cholinesterase inhibition demonstrated in laboratory tests, potentially supporting cognitive function (preliminary evidence) • Antimicrobial properties noted in essential oil studies against various pathogens (preliminary evidence) • Rich source of phenolic compounds including chlorogenic acid (26.8-49.7 mg/g), supporting cellular health (preliminary evidence)
How It Works
Phenolic constituents of Crithmum maritimum, particularly chlorogenic acid and luteolin derivatives, donate hydrogen atoms to neutralize reactive oxygen species, measurable via DPPH, ABTS, and FRAP assays in vitro. Hepatoprotective effects appear mediated through suppression of lipid peroxidation and normalization of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in hepatocyte-stressed animal models. Cholinesterase inhibition is attributed to polyphenol interactions with the active-site serine residue of acetylcholinesterase and butyrylcholinesterase, potentially elevating synaptic acetylcholine levels.
Scientific Research
No human clinical trials, RCTs, or meta-analyses have been conducted on Crithmum maritimum. Current evidence is limited to animal studies showing hepatoprotective effects in chemically intoxicated rats and in vitro assays demonstrating antioxidant and cholinesterase inhibition properties.
Clinical Summary
Research on Crithmum maritimum remains at the preclinical stage with no published randomized controlled trials in humans as of 2024. Animal studies, typically using rodent hepatotoxicity models induced by carbon tetrachloride or similar agents, have reported restoration of liver biomarkers (ALT, AST) and reduced malondialdehyde levels following extract administration. In vitro radical scavenging studies demonstrate IC50 values competitive with standard antioxidants for DPPH and ABTS assays, though these findings do not directly predict human bioavailability or efficacy. Cholinesterase inhibition has been documented in cell-free enzyme assays, but translation to cognitive outcomes in living organisms requires further investigation.
Nutritional Profile
Crithmum maritimum (Rock Samphire/Sea Fennel) contains a diverse array of nutrients and bioactive compounds. Macronutrient composition per 100g fresh weight is approximately: moisture 80-85g, carbohydrates 6-8g, protein 1.5-2.5g, fat 0.3-0.8g, and dietary fiber 2-4g. Micronutrient content is notable for its marine/coastal accumulation profile: vitamin C (ascorbic acid) approximately 30-50mg/100g fresh weight; vitamin E (tocopherols, primarily alpha-tocopherol) approximately 2-5mg/100g; beta-carotene and other carotenoids (lutein, zeaxanthin) in the range of 1-3mg/100g; folate present in moderate amounts (~30-50mcg/100g). Mineral content reflects halophytic nature: potassium (400-600mg/100g), calcium (100-150mg/100g), magnesium (30-50mg/100g), iron (2-4mg/100g), and elevated iodine compared to terrestrial plants. Key bioactive compounds include: essential oil constituents dominated by monoterpene hydrocarbons — dillapiole (phenylpropanoid, up to 20-40% of essential oil), γ-terpinene (15-25%), p-cymene (10-20%), sabinene, and myristicin; phenolic acids including chlorogenic acid, caffeic acid, and rosmarinic acid (total phenolics approximately 15-40mg GAE/g dry extract); flavonoids including isorhamnetin, quercetin, and kaempferol glycosides (approximately 5-15mg/g dry extract); coumarins including isopimpinellin and bergapten (furanocoumarins, photosensitizing potential noted); fatty acids in the lipid fraction are predominantly polyunsaturated, with petroselinic acid (omega-6 isomer) being characteristic. Bioavailability notes: phenolic compounds show moderate bioavailability enhanced by the plant matrix fiber; essential oil volatile compounds are rapidly absorbed but subject to first-pass metabolism; furanocoumarins are bioavailable and warrant caution regarding photosensitivity and potential CYP3A4 interactions; mineral bioavailability may be moderated by oxalate content typical of halophytes.
Preparation & Dosage
No clinically studied dosages in humans are available. Preclinical studies used 20 µL essential oil for antioxidant testing and 0.1 mg/mL for DPPH/FRAP assays. Aqueous extracts contain 26.8-49.7 mg/g chlorogenic acid, but therapeutic dosing has not been established. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Chlorella, Spirulina, Sea buckthorn, Milk thistle, Green tea extract
Safety & Interactions
No formal human safety trials or established tolerable upper intake levels exist for Crithmum maritimum extracts or supplements. Because it contains furanocoumarins, topical or high-dose oral use may theoretically increase photosensitivity, particularly with UV exposure. Individuals taking acetylcholinesterase inhibitor medications (e.g., donepezil, rivastigmine) should exercise caution given additive cholinergic effects, and those on hepatically metabolized drugs should consult a clinician due to uncharacterized CYP enzyme interactions. Pregnant and breastfeeding women should avoid supplemental doses beyond culinary amounts due to the absence of safety data.